| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. | Director | Ordinary Shares | 242K | $375K | $1.55 | Jan 31, 2024 | Direct |
| Allovir, Inc. | Director | Common Stock | 70K | $55.5K | $0.79 | Jun 6, 2024 | Direct |
| 4D Molecular Therapeutics, Inc. | Director | Stock Option (Right To Buy) | 22.5K | May 21, 2024 | Direct | ||
| Cabaletta Bio, Inc. | Director | Stock Option (Right to Buy) | 22K | Jun 3, 2024 | Direct | ||
| Gamida Cell Ltd. | Director | Share Option (Right to Buy) | 17K | Oct 19, 2023 | Direct | ||
| UroGen Pharma Ltd. | Director | Stock Option (right to buy) | 10K | Jun 7, 2021 | Direct | ||
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.74 | Jun 1, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALVR | Allovir, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| CABA | Cabaletta Bio, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 4, 2024 | Director |
| FDMT | 4D Molecular Therapeutics, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| GMDA | Gamida Cell Ltd. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Director |
| GMDA | Gamida Cell Ltd. | Oct 19, 2023 | 1 | $0 | 4/A | Oct 20, 2023 | Director |
| GMDA | Gamida Cell Ltd. | Oct 19, 2023 | 2 | $0 | 4/A | Oct 20, 2023 | Director |
| CABA | Cabaletta Bio, Inc. | Jul 21, 2023 | 1 | $0 | 4 | Jul 24, 2023 | Director |
| CABA | Cabaletta Bio, Inc. | Jul 21, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Director |
| TCRR | TCR2 THERAPEUTICS INC. | Jun 1, 2023 | 4 | $0 | 4 | Jun 1, 2023 | Director |
| FDMT | 4D Molecular Therapeutics, Inc. | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| ALVR | Allovir, Inc. | May 11, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
| GMDA | Gamida Cell Ltd. | Mar 20, 2023 | 1 | $0 | 4 | Mar 22, 2023 | Director |
| GMDA | Gamida Cell Ltd. | Feb 8, 2023 | 2 | $0 | 4 | Feb 10, 2023 | Director |
| TCRR | TCR2 THERAPEUTICS INC. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
| GMDA | Gamida Cell Ltd. | Nov 18, 2022 | 2 | $0 | 4 | Nov 22, 2022 | Director |
| GMDA | Gamida Cell Ltd. | Sep 30, 2022 | 1 | $15K | 4 | Oct 4, 2022 | Director |
| FDMT | 4D Molecular Therapeutics, Inc. | May 23, 2022 | 1 | $0 | 4 | May 25, 2022 | Director |
| ALVR | Allovir, Inc. | May 17, 2022 | 1 | $0 | 4 | May 19, 2022 | Director |
| ALVR | Allovir, Inc. | Mar 29, 2022 | 1 | $0 | 4 | Mar 31, 2022 | Director |
| ALVR | Allovir, Inc. | Mar 29, 2022 | 0 | $0 | 3 | Mar 31, 2022 | Director |
| GMDA | Gamida Cell Ltd. | Jan 1, 2022 | 0 | $0 | 3 | Jan 3, 2022 | Director |
| TCRR | TCR2 THERAPEUTICS INC. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
| URGN | UroGen Pharma Ltd. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
| FDMT | 4D Molecular Therapeutics Inc. | May 17, 2021 | 1 | $0 | 4 | May 19, 2021 | Director |